Among her recent representative matters, Ms. Chunias' representations include:
- Co-led an internal investigation on behalf of the Massachusetts Institute of Technology into its donations from and interactions with Jeffrey Epstein.
- Research misconduct investigations and related litigation on behalf of universities and research institutions. Such representations have included the successful dismissal of a federal lawsuit challenging an institutional research misconduct investigation on behalf of Harvard Medical School.
- An international investment firm in connection with partnership disputes and numerous emergency arbitration proceedings relating to the firm’s investment in certain medical cannabis entities, ultimately negotiating a favorable settlement and return of the firm’s investment.
- A global technology company in connection with civil False Claims Act qui tam litigation and criminal investigations by the U.S. Attorney's Office and the U.S. Department of Justice, National Security Division, relating to defense contracts and allegations of visa fraud, contract fraud, and ITAR violations.
- A prominent international private equity firm in post-closing litigation in Delaware Chancery Court in its capacity as shareholder representative of the former shareholders of Microban International, Ltd. against W.M. Barry & Company, Inc.
- A U.S. publicly-traded software company in federal court post-closing litigation seeking indemnification for numerous fiduciary and restrictive covenant breaches, ultimately negotiating a highly favorable settlement.
- A U.S. publicly-traded global manufacturer of scientific and diagnostic instruments in connection with investigations by the SEC, DOJ and Hong Kong Independent Commission Against Corruption into alleged bribery and corruption violations at several of the Company's China subsidiaries.
- A global private equity firm that has raised over $18 billion of capital in connection with an arbitration involving claims of fraud and breach of fiduciary duty. Ms. Chunias was a member of the Goodwin team that ultimately obtained a $170 million award and defeated over $100 million in counterclaims.
- The former CEO of a pharmaceutical and medical device company in connection with a federal indictment relating to the company's sale of allegedly unapproved and adulterated drugs.
- A private healthcare consulting firm in connection with multiple FCA qui tam whistleblower suits arising out of allegations that the company assisted hospitals seeking and receiving inflated Medicare and Medicaid reimbursements.
- A national pension consulting firm in connection with claims relating to the Madoff Ponzi scheme.
- The principals of The Pyramid Companies, a multi-billion dollar commercial real estate firm in connection with a breach of fiduciary duty suit brought by a minority partner seeking to dissolve and liquidate one of The Pyramid Companies’ asset-holding general partnerships valued at over $200 million. Ms. Chunias was part of a Goodwin team that defeated all fiduciary duty claims against the principals and obtained judgment after a three-week trial that the minority partner had wrongfully attempted to dissolve the partnership.
- The buyers of National Manufacturing, Inc. in an arbitration and numerous post-arbitration litigation proceedings after obtaining an award that sellers had breached environmental warranties and were responsible for full environmental remediation costs.
In 2016, Ms. Chunias was appointed by Massachusetts Governor Charlie Baker to the State Ballot Law Commission.
Ms. Chunias has served on the Board of the Women's Bar Foundation, on the BBA's Individual Rights Responsibilities Section Steering Committee, and as a pro bono Bar Advocate, handling dozens of court appointments in the Criminal Division of the Boston Municipal Court.
Prior to joining Goodwin in 2005, Ms. Chunias was a lecturer at Harvard Law School. Before that, she was an associate in the Litigation Practice Group at Testa, Hurwitz & Thibeault, LLP in Boston.